11.02.16
INDIA: Azelis announces its appointment as exclusive distributor by Tagra Biotechnologies, to offer its range of RND microencapsulated actives and pigments in India, Australia and New Zealand for all personal care applications.
This new partnership builds on agreements between the two companies in Europe and Canada.
“Tagra looks forward to extending our successful partnership with Azelis into India, Australia and New Zealand. Together we aim to offer customers high quality technical service and innovative application insights. Azelis has proven to be a trusted and dynamic partner. We work well together and the decision to extend our partnership was a natural one,” said Lito Ickowicz, director business development, Tagra Biotechnologies.
“We are delighted to expand our partnership with Tagra into the Asia Pacific region,” noted Laurent Nataf, CEO and president Asia Pacific. “Tagra’s highly innovative ingredients are a welcome addition to our portfolio, fitting well with our strategy to focus on specialties and create value for our Asia Pacific customers.”
Tagra Biotechnologies is a leader in Release on Demand (RND) Microencapsulation Technology, a patented method providing stability, efficiency and controlled/immediate release for non-water soluble ingredients.
More info: www.azelis.com
This new partnership builds on agreements between the two companies in Europe and Canada.
“Tagra looks forward to extending our successful partnership with Azelis into India, Australia and New Zealand. Together we aim to offer customers high quality technical service and innovative application insights. Azelis has proven to be a trusted and dynamic partner. We work well together and the decision to extend our partnership was a natural one,” said Lito Ickowicz, director business development, Tagra Biotechnologies.
“We are delighted to expand our partnership with Tagra into the Asia Pacific region,” noted Laurent Nataf, CEO and president Asia Pacific. “Tagra’s highly innovative ingredients are a welcome addition to our portfolio, fitting well with our strategy to focus on specialties and create value for our Asia Pacific customers.”
Tagra Biotechnologies is a leader in Release on Demand (RND) Microencapsulation Technology, a patented method providing stability, efficiency and controlled/immediate release for non-water soluble ingredients.
More info: www.azelis.com